![]() |
市場調查報告書
商品編碼
2024164
再生種子處理市場預測至2034年-按產品類型、作物類型、功能、配方、最終用戶、分銷管道和地區分類的全球分析Regenerative Seed Treatment Market Forecasts to 2034 - Global Analysis By Product Type, Crop Type, Function, Formulation, End User, Distribution Channel, and By Geography |
||||||
根據 Stratistics MRC 的數據,預計到 2026 年,全球再生種子處理市場規模將達到 42 億美元,並在預測期內以 13.7% 的複合年成長率成長,到 2034 年將達到 118 億美元。
再生種子處理是指在播種前對種子施用生物製劑、微生物製劑、有機製劑、植物萃取物和營養製劑。這些處理方法能夠促進幼苗成活,刺激植物免疫系統的激活,透過增強根際微生物群落來提高養分吸收,透過競爭性生物機制抑制土壤傳播的病原體,並減少作物系統向以恢復土壤健康、生物多樣性和減少合成材料使用為優先的再生農業實踐過渡時對合成化學種子處理的依賴。
擴大再生農業的引進
農民們迅速採用再生農業實踐,旨在減少對合成化學品的依賴,改善土壤生物多樣性,並從永續性認證的作物供應鏈中獲得溢價,這正在加速對符合再生農業系統要求的生物和有機種子處理產品的需求。大型食品飲料公司在其供應鏈中永續性舉措,以及對農民轉型計畫的資助,正在為再生種子處理產品建立超越傳統農業零售管道的機構採購管道。
生物效應的差異
生物種子處理的效果會因土壤類型、氣候條件和現有土壤微生物群落組成而異,導致田間試驗結果的重複性較差。這使得農民難以可靠地預測生物種子處理產品對產量和作物出苗性能的影響,從而導致他們傾向於選擇昂貴的生物替代品,而不是在各種農業環境中性能更可預測且經過驗證的化學合成處理方法。
融入碳農業計劃
將再生種子處理技術納入農業碳匯計畫的參與需求,為市場拓展提供了契機。透過允許排碳權計畫營運者和再生農業認證機構將生物種子處理技術作為一項認可的實踐納入核准的碳封存和土壤健康改善實踐框架,可以向採用生物種子處理的農民提供碳支付獎勵,幫助他們向更廣泛的再生農業系統轉型。
在傳統治療劑市場佔據主導地位
用於種子處理的傳統合成殺菌劑、殺蟲劑和聚合物包衣市場由根深蒂固的分銷關係、農藝師對推薦產品的習慣以及完善的產品性能文件所主導,這些因素對再生種子處理替代方案的市場佔有率構成了重大障礙。在對成本高度敏感的農業市場中,替代方案必須克服從現有產品轉換的成本、技術偏好慣性以及傳統產品相對於高階生物製藥的單位處理成本優勢。
新冠疫情導致的供應鏈中斷影響了合成農藥的供應,暫時提升了農民對生物替代方法(包括種子處理)的興趣,並加速了再生種子處理產品的試點推廣。疫情期間消費者對永續食品的需求增加,促使零售商和食品品牌加大對供應鏈永續性項目的投入,也增強了農民採用再生農業實踐(包括生物種子處理)的獎勵。後疫情時代再生農業計畫的擴展將繼續推動生物種子處理市場的成長。
在預測期內,以營養物質為基礎的加工領域預計將成為最大的細分市場。
在預測期內,營養型種子處理劑預計將佔據最大的市場佔有率。這是因為農民普遍體認到,添加磷、鋅和微量元素的營養種子處理提案能夠改善幼苗存活率,進而提升幼苗的存活率。這種處理方法能夠解決幼苗成活關鍵階段的土壤養分不足問題,而根系發育在這一階段決定了作物的產量潛力。在全球不同的種植系統中,這種處理方法都對營養強化型種子披衣產品產生了穩定的需求,無論是在傳統農業還是再生農業領域。
預計在預測期內,糧食產業將呈現最高的複合年成長率。
在預測期內,穀物和穀類產業預計將呈現最高的成長率,這主要得益於小麥、玉米和大豆生產系統中生物種子處理的大規模應用。這是因為主要穀物商品的供應鏈已認知到生物種子處理是一種能夠改善土壤健康的有效方法,其在改善根際微生物群方面具有顯著效果,從而促進了再生農業實踐的推廣,以滿足食品公司對永續性採購的需求。
在預測期內,北美預計將佔據最大的市場佔有率。這是因為美國擁有成熟的生物種子處理產業,Corteva Agriscience、BASF和Valent Biosciences等主要企業在國內創造了可觀的收入;農民對生物種子處理表現出濃厚的興趣,這主要得益於其成本效益以及參與再生農業項目的獎勵;此外,北美還擁有完善的農產品基礎設施,能夠確保創新型種子處理產品獲得廣泛的市場進入。
在預測期內,亞太地區預計將呈現最高的複合年成長率。這主要歸因於以下幾個因素:印度、中國和東南亞國家大規模實施有機和永續農業項目,這些項目需要採用生物種子處理技術;印度和中國國內生物農業材料產業的成長;以及出口市場對永續性要求的不斷提高,這些都獎勵著亞洲主要農產品出口生產系統中的農民採用包括生物種子處理在內的再生農業實踐。
According to Stratistics MRC, the Global Regenerative Seed Treatment Market is accounted for $4.2 billion in 2026 and is expected to reach $11.8 billion by 2034 growing at a CAGR of 13.7% during the forecast period. Regenerative seed treatments refer to biological, microbial, organic, botanical extract, and nutrient-based preparations applied to crop seeds prior to planting that enhance seedling establishment, stimulate plant immune system priming, improve nutrient uptake through rhizosphere microbiome enhancement, suppress soil-borne pathogens through competitive biological mechanisms, and reduce synthetic chemical seed treatment dependency in cropping systems transitioning toward regenerative agriculture practices that prioritize soil health regeneration, biological diversity, and reduced synthetic input use.
Regenerative Agriculture Adoption Growth
Rapidly growing farmer adoption of regenerative agriculture practices seeking to reduce synthetic chemical input dependency, improve soil biology, and access premium market premiums from sustainability-certified crop supply chains is driving accelerating demand for biological and organic seed treatment products aligned with regenerative farming system requirements. Major food and beverage company supply chain sustainability commitments funding farmer transition programs are generating institutional procurement channels for regenerative seed treatment products beyond conventional agricultural retail distribution.
Biological Efficacy Variability
Biological seed treatment performance variability across different soil types, climate conditions, and existing soil microbiome compositions creates inconsistent field trial outcome reproducibility that makes it difficult for farmers to predict reliable yield and establishment performance benefits from biological seed treatment products, generating risk aversion toward premium biological alternatives compared to chemically defined synthetic treatments with more predictable and well-documented performance characteristics across diverse agricultural environments.
Carbon Farming Program Integration
Integration of regenerative seed treatment adoption within agricultural carbon program participation requirements represents a market expansion opportunity as carbon credit program operators and regenerative agriculture certification bodies incorporate biological seed treatment as a recognized practice within approved carbon sequestration and soil health enhancement practice frameworks that generate carbon payment incentives for farmers adopting biological seed treatment within broader regenerative farming system transitions.
Conventional Treatment Market Dominance
Conventional synthetic fungicide, insecticide, and polymer coating seed treatment market dominance with deeply established distribution relationships, agronomist recommendation familiarity, and robust product performance documentation creates significant market share capture barriers for regenerative seed treatment alternatives that must overcome incumbent switching costs, technical preference inertia, and lower per-unit treatment cost advantages that conventional products maintain over premium biological formulations in cost-sensitive agricultural markets.
COVID-19 supply chain disruptions affecting synthetic agricultural chemical availability created temporary farmer interest in biological alternatives including seed treatments that accelerated trial adoption of regenerative seed treatment products. Pandemic-era acceleration of consumer sustainable food demand amplified retailer and food brand supply chain sustainability program investment that increased farmer incentive for regenerative practice adoption including biological seed treatment. Post-pandemic regenerative agriculture program expansion continues driving biological seed treatment market growth.
The nutrient-based treatments segment is expected to be the largest during the forecast period
The nutrient-based treatments segment is expected to account for the largest market share during the forecast period, due to broad farmer familiarity with nutrient seed treatment value propositions for improved seedling establishment through phosphorus, zinc, and micronutrient loading that addresses soil nutrient deficiency at the critical seedling establishment stage when root system development determines crop yield potential across diverse cropping systems globally, generating consistent demand for nutrient-enhanced seed coating products across both conventional and transitioning regenerative farming operations.
The cereals & grains segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the cereals & grains segment is predicted to witness the highest growth rate, driven by large-scale adoption of biological seed treatments in wheat, corn, and soybean production systems as major grain commodity supply chains respond to food company sustainability procurement requirements by incentivizing regenerative farming practice adoption that includes biological seed treatment as a recognized soil health enhancement practice with documented rhizosphere microbiome improvement outcomes.
During the forecast period, the North America region is expected to hold the largest market share, due to the United States hosting a mature biological seed treatment industry with leading companies including Corteva Agriscience, BASF, and Valent Biosciences generating substantial domestic revenue, strong farmer interest in biological seed treatment driven by cost-benefit economics and regenerative agriculture program participation incentives, and well-developed agribusiness distribution infrastructure enabling broad market access for innovative seed treatment products.
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, due to India, China, and Southeast Asian countries implementing large-scale organic and sustainable agriculture programs requiring biological seed treatment adoption, growing domestic biological agricultural input industries in India and China, and expanding export market sustainability requirements creating farmer incentive for regenerative practice adoption including biological seed treatment across major Asian agricultural export crop production systems.
Key players in the market
Some of the key players in Regenerative Seed Treatment Market include Bayer AG, Syngenta Group, Corteva Agriscience, BASF SE, UPL Limited, FMC Corporation, Nufarm Ltd., Valent Biosciences, Novozymes, Chr. Hansen, Bioceres Crop Solutions, Koppert Biological Systems, Terramera, Groundwork BioAg, AgBiome, Rizobacter, and Sumitomo Chemical.
In March 2026, Novozymes launched a new multi-strain biological seed treatment combining nitrogen-fixing, phosphate-solubilizing, and plant growth-promoting rhizobacteria in a single application for corn and soybean production.
In February 2026, Bioceres Crop Solutions expanded its HB4 stress-tolerant biological seed treatment platform to European wheat markets following regulatory approvals, targeting premium grain supply chain sustainability certification programs.
In January 2026, Koppert Biological Systems introduced a new mycorrhizal fungi seed coating product enhancing phosphorus uptake efficiency in low-input farming systems with documented fertilizer reduction benefits verified through multi-year field trials.
Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) Regions are also represented in the same manner as above.